title: Monkeypox disease transmission in an experimental setting: prairie dog animal model.
abstract: Monkeypox virus (MPXV) is considered the most significant human public health threat in the genus Orthopoxvirus since the eradication of variola virus (the causative agent of smallpox). MPXV is a zoonotic agent endemic to forested areas of Central and Western Africa. In 2003, MPXV caused an outbreak in the United States due to the importation of infected African rodents, and subsequent sequential infection of North American prairie dogs (Cynomys ludovicianus) and humans. In previous studies, the prairie dog MPXV model has successfully shown to be very useful for understanding MPXV since the model emulates key characteristics of human monkeypox disease. In humans, percutaneous exposure to animals has been documented but the primary method of human-to-human MPXV transmission is postulated to be by respiratory route. Only a few animal model studies of MPXV transmission have been reported. Herein, we show that MPXV infected prairie dogs are able to transmit the virus to naive animals through multiple transmission routes. All secondarily exposed animals were infected with MPXV during the course of the study. Notably, animals secondarily exposed appeared to manifest more severe disease; however, the disease course was very similar to those of experimentally challenged animals including inappetence leading to weight loss, development of lesions, production of orthopoxvirus antibodies and shedding of similar levels or in some instances higher levels of MPXV from the oral cavity. Disease was transmitted via exposure to contaminated bedding, co-housing, or respiratory secretions/nasal mucous (we could not definitively say that transmission occurred via respiratory route exclusively). Future use of the model will allow us to evaluate infection control measures, vaccines and antiviral strategies to decrease disease transmission.
authors.affiliation: Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Disease, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America. CHutson1@cdc.gov
authors.forename: Christina L
authors.initials: CL
authors.lastname: Hutson
authors.forename: Darin S
authors.initials: DS
authors.lastname: Carroll
authors.forename: Nadia
authors.initials: N
authors.lastname: Gallardo-Romero
authors.forename: Sonja
authors.initials: S
authors.lastname: Weiss
authors.forename: Cody
authors.initials: C
authors.lastname: Clemmons
authors.forename: Christine M
authors.initials: CM
authors.lastname: Hughes
authors.forename: Johanna S
authors.initials: JS
authors.lastname: Salzer
authors.forename: Victoria A
authors.initials: VA
authors.lastname: Olson
authors.forename: Jason
authors.initials: J
authors.lastname: Abel
authors.forename: Kevin L
authors.initials: KL
authors.lastname: Karem
authors.forename: Inger K
authors.initials: IK
authors.lastname: Damon
mesh_terms: D000818:Animals; D003140:Communicable Disease Control; D004279:DNA, Viral / Q000378:metabolism; D004195:Disease Models, Animal; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D006801:Humans; D045908:Mpox, Monkeypox / Q000635:transmission* / Q000662:veterinary; D008993:Monkeypox virus / Q000378:metabolism*; D009666:Nose / Q000473:pathology; D016133:Polymerase Chain Reaction / Q000379:methods; D012119:Respiration; D012137:Respiratory System / Q000821:virology; D012589:Sciuridae
chemical_list: D004279:DNA, Viral